From FDA email, Nov. 25: You may have noticed that cannabidiol (CBD) seems to be available almost everywhere, and marketed in a variety of products including drugs, food, dietary supplements, cosmetics and animal health products. Other than one prescription drug product to treat two rare, severe forms of epilepsy, the U.S. Food and Drug Administration (FDA) has not approved any other CBD products, and there is very limited clinically validated information about CBD, including about its effects on the body.
The FDA recognizes the significant public interest in cannabis and cannabis-derived compounds, particularly CBD. However, there are many unanswered questions about the science, safety and quality of products containing CBD. The agency is working on answering these questions through ongoing efforts including feedback from a recent FDA hearing and information and data gathering through a public docket. Check out the FDA’s web page on CBD.